AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,358,000 | -16.4% | 74,100 | -8.2% | 0.00% | 0.0% |
| Q4 2020 | $1,624,000 | +5.2% | 80,736 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $1,544,000 | -12.4% | 82,336 | +5.0% | 0.00% | -50.0% |
| Q2 2020 | $1,762,000 | +48.9% | 78,436 | -1.6% | 0.00% | +100.0% |
| Q1 2020 | $1,183,000 | -49.6% | 79,736 | -34.5% | 0.00% | -50.0% |
| Q4 2019 | $2,348,000 | +9.4% | 121,702 | +12.4% | 0.00% | 0.0% |
| Q3 2019 | $2,147,000 | +48.5% | 108,261 | +58.1% | 0.00% | 0.0% |
| Q2 2019 | $1,446,000 | -1.1% | 68,487 | -4.3% | 0.00% | 0.0% |
| Q1 2019 | $1,462,000 | +187.2% | 71,540 | +179.7% | 0.00% | +100.0% |
| Q4 2018 | $509,000 | – | 25,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alambic Investment Management, L.P. | 29,423 | $583,000 | 0.44% |
| Matarin Capital Management, LLC | 223,184 | $4,426,000 | 0.34% |
| Summit Global Investments | 42,725 | $847,000 | 0.10% |
| FEDERATED HERMES, INC. | 1,747,921 | $34,661,000 | 0.08% |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 347,307 | $6,887,000 | 0.08% |
| MARSHALL WACE, LLP | 413,293 | $8,196,000 | 0.06% |
| BOSTON ADVISORS LLC | 42,365 | $840,000 | 0.04% |
| MARTINGALE ASSET MANAGEMENT L P | 214,444 | $4,254,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 177,321 | $3,516,000 | 0.04% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 231,041 | $4,582,000 | 0.04% |